UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of April 2022
Commission File Number 001-38367
SOL-GEL TECHNOLOGIES LTD.
(Translation of registrant’s name into English)
7 Golda Meir Street
Ness Ziona 7403650, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On April 19, 2022, Sol-Gel Technologies Ltd. (the “Company”) entered into an Open Market Sale AgreementSM (the “Sale Agreement”) with Jefferies LLC (“Jefferies”), pursuant to which the Company may offer and sell its ordinary shares, par value NIS 0.1 per share (the “Shares”), from time to time, through Jefferies as its sales agent. The offer and sale of the Shares that may be sold pursuant to the Sale Agreement will be made pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-264190), as supplemented by the prospectus supplement dated April 19, 2022 relating to the sale of the Shares. Pursuant to the prospectus supplement, the Company may offer and sell Shares having an aggregate offering price of up to $23,000,000.
Upon entry into the Sale Agreement, the Company and Jefferies terminated that certain Open Market Sale AgreementSM, dated January 10, 2020, by and between the Company and Jefferies.
Attached hereto and incorporated by reference in this Report on Form 6-K are the following exhibits:
This Report on Form 6-K is hereby incorporated by reference into the Company's Registration Statement on Form F-3 (Registration No. 333-264190).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SOL-GEL TECHNOLOGIES LTD. | |||
Date: April 19, 2022 | By: | /s/ Gilad Mamlok | |
Gilad Mamlok | |||
Chief Financial Officer |
3